Alchemee LLC,
The consumers’ theory is “essentially an attack” on the US Food and Drug Administration’s determination that over-the-counter drugs with benzoyl peroxide are safe, effective, and not misbranded if the products comply with their monograph, the US District Court for the Central District of California said Thursday. The consumers’ claims were preempted by the Federal Food, Drug, and Cosmetics Act, and Judge Stanley Blumenfeld Jr. dismissed the class actions with ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.